# Biopreparations for bee health Biological preparations that protect managed bees — honeybee vaccines, probiotic and microbiome treatments, pathogen biocontrol and seaweed/botanical feed supplements that cut Nosema, foulbrood and virus losses and shore up the >$15B crop-pollination market. Source: https://en.bioecon.ru/technology/bee-health-biopreparations/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: EU Pollinators Initiative & Farm to Fork | OECD: Agricultural Biotechnology | Regulator: USDA-CVB/EPA (USA), EFSA (EU), MoA (China)] Biopreparations for bee health are live-microbe, vaccine and botanical preparations that protect managed honeybees and bumblebees from American foulbrood, Nosema, viruses and the Varroa mite — the drivers of the record colony losses that threaten a U.S. crop-pollination market worth more than $15B a year. Dalan Animal Health's American-foulbrood vaccine, the first honeybee vaccine to receive USDA conditional licensure (December 2022), primes the queen against Paenibacillus larvae and passes protection to her offspring through trans-generational immunity. On the probiotic side, Lactobacillus melliventris raised Bombus terrestris colony survival 2.5-fold with more than 10% more flowers visited, while Vita's HiveAlive seaweed-and-thymol supplement delivered up to an 89% colony-population gain, 40% more honey and 57% fewer Nosema spores in independent trials. The category spans vaccines, probiotics, pathogen biocontrol and nutrition supplements. The key directions of bee-health biopreparations are: 1. **Honeybee vaccines (Honeybee Vaccines):** prime the queen via trans-generational immune priming so her offspring resist Paenibacillus larvae (American foulbrood) — Dalan's USDA-conditionally-licensed vaccine. 2. **Probiotic and microbiome preparations (Bee Probiotic & Microbiome Preparations):** native gut bacteria such as Lactobacillus melliventris and engineered yeast that colonize the bee gut and lift colony survival and pollination performance. 3. **Pathogen biocontrol (Bee Pathogen Biocontrol):** biological agents targeting Varroa, foulbrood and bee viruses (dsRNA/RNAi antivirals, entomopathogenic fungi). 4. **Nutrition and immunity supplements (Bee Nutrition & Immunity Supplements):** seaweed, thymol and propolis-based feed additives (Vita HiveAlive, Beeflow Max Poll) that boost gut health and cold tolerance. ### Sectoral value chain ``` [pathogen/microbe isolation] ──> [strain/vaccine design] ──> [formulation] ──> [hive administration] │ (prime colony immunity) │ ▼ [pollination service] <─── [colony monitoring] <─────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Pathogen/Microbe Isolation** | isolate bee pathogens and candidate gut probiotics from healthy colonies | **In:** bee samples, gut isolates. **Out:** pathogen strains, probiotic candidates. | | **Strain/Vaccine Design** | select or engineer the probiotic strain or vaccine antigen (e.g. Paenibacillus antigen) | **In:** isolates, antigen maps. **Out:** vaccine or strain candidate. | | **Formulation** | stabilize as queen candy, liquid feed supplement, pollen patty or spray | **In:** carriers, thymol/seaweed/lecithin. **Out:** hive-ready product. | | **Hive Administration** | deliver via the queen (vaccine), feed (probiotic/supplement) or topical treatment | **In:** product, hives. **Out:** treated colonies. | | **Colony Health Monitoring** | track Nosema spore load, overwinter survival and virus titres | **In:** hive samples, sensors. **Out:** health indices. | | **Pollination/Service Delivery** | integrate with beekeeping IPM and pollination operations | **In:** treated colonies, crop plans. **Out:** pollination + health service. | Cross-cutting technologies of the sector: - **Trans-generational immune priming (Trans-Generational Immune Priming):** vaccinating the queen so egg jelly conveys pathogen resistance to offspring — the mechanism behind Dalan's foulbrood vaccine. - **Bee gut microbiome engineering (Bee Gut Microbiome Engineering):** native and engineered bacteria/yeast (Lactobacillus, engineered Saccharomyces) that colonize the gut and deliver protection. - **dsRNA/RNAi antivirals (dsRNA/RNAi Antivirals):** double-stranded RNA targeting bee viruses (Deformed Wing Virus) and Varroa, an emerging biocontrol class. --- ## US The US anchors the category with the first honeybee vaccine and data-driven pollination-health services, against the backdrop of a >$15B pollination market and chronically high winter colony losses. ### honeybee vaccine, pollination-health biotech, USDA-CVB licensure - **Dalan Animal Health:** the first honeybee vaccine, targeting American foulbrood (Paenibacillus larvae), received USDA conditional licensure in December 2022; 2025 efficacy trials (also correlated with reduced Deformed Wing Virus) support a move to full licensure, targeted for the 2027 season, delivered to queens via candy to trigger trans-generational immunity. - **Beeflow:** a pollination-biotech firm whose Max Poll supplement boosts bee immunity and cold tolerance so flights continue below 50°F; across 36 U.S. trials it delivered 18% more blueberry flower visits and a sevenfold rise in flights at suboptimal temperatures, operating across Chile, Peru, Mexico, Brazil and the U.S. - **USDA-CVB/EPA framing:** the USDA Center for Veterinary Biologics licenses bee vaccines while the EPA registers hive-applied microbial and botanical treatments, together setting the U.S. route to market. --- ## CN China, the world's largest beekeeping and honey producer, pairs a propolis-and-royal-jelly industry with state-led bee-disease biocontrol research under the Ministry of Agriculture. ### propolis/bee-product preparations, CAAS bee-disease biocontrol, MARA framework - **Hengliang Bee Industry (恒亮蜂业):** a Zhejiang-Jiangshan bee-products firm producing propolis, royal jelly and hive-health preparations grounded in China's propolis-rich traditional apitherapy, the basis for antimicrobial hive treatments. - **CAAS Bee Research Institute:** the Chinese Academy of Agricultural Sciences' bee-research arm systematizes bee-disease prevention and biocontrol — covering foulbrood, Varroa and sacbrood — and underpins China's national bee-health guidance. - **MARA framework:** microbial and botanical hive treatments register under the Ministry of Agriculture's veterinary/biological-input track, framing the route to market for Chinese bee-health biopreparations. --- ## EU The EU combines the leading bumblebee-biocontrol industry with science-led honeybee therapeutics, framed by the EU Pollinators Initiative and Farm to Fork. ### bumblebee probiotics, seaweed/thymol supplements, EU Pollinators Initiative - **Biobest:** a Belgian bumblebee and biological-control leader whose bee-microbiome work builds on Lactobacillus melliventris — a native bumblebee gut bacterium that lifted Bombus terrestris colony survival 2.5-fold and increased flowers visited by more than 10% in greenhouse trials. - **Vita Bee Health (UK):** the HiveAlive feed supplement (Irish seaweed extracts, thymol, lemongrass oil and lecithin) delivered up to an 89% colony-population increase, 40% more honey, 57% fewer Nosema spores and 15% lower overwinter mortality in independent (Hellenic Institute of Apiculture) trials. - **EU Pollinators Initiative:** the framework ties bee-health product uptake to pollinator-protection targets, while EFSA evaluates microbial and botanical hive treatments entering the EU market. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Dalan Animal Health** | 🇺🇸 USA | *American foulbrood honeybee vaccine* | first USDA-conditionally-licensed bee vaccine, trans-generational immunity | Commercial | | **Beeflow** | 🇺🇸 USA | *Max Poll pollination supplement* | +18% blueberry visits, 7× flights <50°F, 5+ countries | Commercial | | **Biobest** | 🇧🇪 Belgium | *bumblebee probiotics / biocontrol* | L. melliventris 2.5× survival, +10% flowers visited | Commercial | | **Vita Bee Health** | 🇬🇧 UK | *HiveAlive feed supplement* | seaweed+thymol: +89% colony, +40% honey, −57% Nosema | Commercial | | **Hengliang Bee Industry** | 🇨🇳 China | *propolis / royal-jelly preparations* | antimicrobial propolis-based hive-health products | Commercial | | **CAAS Bee Research Institute** | 🇨🇳 China | *bee-disease biocontrol research* | foulbrood/Varroa/sacbrood biocontrol science | Research | --- ## Tech stack and innovations The stack pairs immune-priming vaccines with gut-microbiome engineering and botanical/nutritional supplements. 1. **Trans-generational immune-priming vaccines (Honeybee Immune-Priming Vaccines):** - Dalan primes the queen against Paenibacillus larvae so worker jelly conveys resistance to eggs, the basis of the first USDA-conditionally-licensed honeybee vaccine. - The platform extends toward Deformed Wing Virus, with trial correlations showing reduced DWV in vaccinated colonies. 2. **Probiotic and microbiome therapeutics (Bee Gut Microbiome Therapeutics):** - Biobest's Lactobacillus melliventris colonizes Bombus terrestris, persisting long-term and lifting survival 2.5-fold with more than 10% more flowers visited. - Engineered yeast (Saccharomyces) delivering dsRNA extends the microbiome route toward antiviral protection against bee viruses. 3. **Botanical and nutritional supplements (Botanical & Nutritional Supplements):** - Vita's HiveAlive blends Irish seaweed extracts with thymol, lemongrass oil and lecithin to cut Nosema spores 57% and raise colony population up to 89% in independent trials. - Beeflow's Max Poll feeds bees to lift immunity and cold tolerance, extending the pollination window below 50°F for an 18% gain in blueberry flower visits. --- ## Value chains and production pipelines ### Industrial pipeline of a bee-health biopreparation (USDA-CVB / EPA / EFSA / MARA registration) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Pathogen/microbe │ ───> │ 2. Strain/vaccine design │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Hive administration │ <─── │ 3. Formulation │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Colony monitoring │ ───> │ 6. Pollination service │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Pathogen/microbe isolation Bee pathogens (Paenibacillus larvae, Melissococcus plutonius, Nosema) and candidate gut probiotics (Lactobacillus, Bifidobacterium, Snodgrassella) are isolated from healthy and diseased colonies; the output is a panel of target pathogens and probiotic candidates. #### Stage 2: Strain/vaccine design A probiotic strain is selected or engineered (e.g. Lactobacillus melliventris, dsRNA-delivering yeast) or a vaccine antigen is mapped (Paenibacillus larvae antigen for trans-generational priming); the output is a vaccine or strain candidate. #### Stage 3: Formulation The candidate is stabilized as queen candy (vaccine), a liquid feed supplement or pollen patty (probiotic/seaweed-thymol blend), or a spray; Vita's HiveAlive also stabilizes syrup for roughly five months, and the output is a hive-ready product. #### Stage 4: Hive administration The product is delivered to the queen (vaccine candy for trans-generational immunity), fed to the colony (probiotic or supplement), or applied topically; the output is a cohort of treated colonies. #### Stage 5: Colony monitoring Nosema spore load, overwinter survival and virus titres are tracked across the season — the 57% Nosema reduction and 15% lower overwinter mortality seen with HiveAlive exemplify the measurable outcomes; the output is a colony-health record. #### Stage 6: Pollination service Treated colonies are integrated into beekeeping integrated pest management and pollination operations — Beeflow's 18% gain in blueberry visits closes the loop from hive health to pollination productivity, registered under USDA-CVB/EPA, EFSA or MARA frameworks.